Zobrazeno 1 - 10
of 37
pro vyhledávání: '"J J, Ashford"'
Autor:
P Cowen, C Thompson, A Roberts, J Nakielny, S Eckett, I Hindmarch, J S Kerr, J J Ashford, J A Henry, A S Hale, D Tracey, R Gonzaga, P Naik, A Brandt, R Bergemann, B K Puri, J H Thakore, N Feemantle, T A Sheldon, F Song, J Mason, A House
EDITOR, - N Freemantle and colleagues propose that, compared with selective serotonin reuptake inhibitors, “newer tricyclic and related antidepresants … will have similar impact on rates of suicide but at considerably less cost.”1 The drugs tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b972c4b05ea8e31bf7b905ca20604975
https://doi.org/10.1136/bmj.309.6961.1082
https://doi.org/10.1136/bmj.309.6961.1082
Publikováno v:
International Journal of Clinical Practice. 45:255-258
Publikováno v:
Current Medical Research and Opinion. 12:234-241
The efficacy and CNS effects of the selective 5-HT re-uptake inhibitor fluvoxamine were compared with mianserin in depressed hospital out-patients in a double-blind randomized trial. Patients had to meet DSM-III criteria for Major Depressive Episode
Autor:
A M Whitehead, J J Ashford
Publikováno v:
International Journal of Clinical Practice. 46:21-23
Autor:
J J, Ashford
Publikováno v:
International clinical psychopharmacology. 9
The tricyclic antidepressants (TCAs) are still considered as first-line treatment for depression, despite the availability of the selective serotonin reuptake inhibitors (SSRIs). This paper considers the current situation in reverse by assuming that
Publikováno v:
The Journal of clinical psychiatry. 55(7)
To examine the efficacy of fluvoxamine and clomipramine in obsessive compulsive disorder and to compare their tolerabilities.In this multicenter, randomized, double-blind trial, fluvoxamine (100-250 mg/day) was compared with clomipramine (100-250 mg/
Autor:
A M, Whitehead, J J, Ashford
Publikováno v:
The British journal of clinical practice. 46(1)
A series of double-blind hospital based studies comparing fluvoxamine with other antidepressants in depressed patients is reviewed. Overall there were no significant differences in terms of efficacy between fluvoxamine and the comparators (amitriptyl
Publikováno v:
British journal of clinical pharmacology. 31(2)
Publikováno v:
The British journal of clinical practice. 45(4)
The efficacy and tolerability of the selective 5-HT reuptake inhibitor fluvoxamine were compared with the tricyclic dothiepin in 52 elderly (age greater than 64 years) hospital patients in a multi-centre double-blind randomised trial. Patients met DS
Autor:
J J Ashford
Publikováno v:
British Journal of Psychiatry. 164:852-853